TORONTO, September 27, 2024—BenchSci, a world leader in AI solutions for preclinical research and drug discovery, is pleased to announce its inclusion in the 2024 Report on Business magazine’s ranking of Canada’s Top Growing Companies.
Canada’s Top Growing Companies ranks Canadian companies based on three-year revenue growth. BenchSci earned its spot with a three-year growth of 191%.
We’re honoured to be recognized as one of Canada’s fastest-growing companies. This achievement is a testament to our incredible team, who are passionate and dedicated to building a company that accelerates scientific breakthroughs,” says Liran Belenzon. “We have a strong vision for the future and look forward to continuing to work with scientists and pharmaceutical companies around the world to bring new medicines to patients faster.”
BenchSci’s inclusion in this list underscores the company’s impact on drug discovery. By harnessing the power of AI, BenchSci’s ASCEND platform is transforming preclinical research and development (R&D) within the pharmaceutical industry. Today, ASCEND serves as an AI assistant for the brightest scientists at leading pharmaceutical companies. Its cutting-edge technology decodes and connects the vast landscape of biomedical research, multi-omics data, and integrates it with proprietary customer data. This creates an unbiased map of the underlying biology of disease, empowering scientists to discover novel insights and accelerate R&D.
Canada’s Top Growing Companies is an editorial ranking that was launched in 2019 to celebrate the achievements of innovative businesses in Canada. To qualify for this voluntary program, companies had to complete an in-depth application process and fulfill revenue requirements. In total, 417 companies earned a spot on this year’s ranking.
The full list of 2024 winners along with editorial coverage is published in the October issue of Report on Business magazine. The list is out now and online here.
“Our annual ranking of Canada’s Top Growing Companies reflects the sector-spanning ingenuity of this country’s entrepreneurs and corporate leaders,” says Dawn Calleja, Editor of Report on Business magazine. “And we think it’s important to tell their stories, to help inspire the next generation of up-and-comers across the country.”
"The Globe and Mail congratulates this year's Canada's Top Growing Companies' winners for achieving exceptional growth and resilience in facing business challenges," says Andrew Saunders, CEO of The Globe and Mail. “It is a testament to dedication, strategic vision, and innovative drive.”
About BenchSci
BenchSci is a world leader in AI solutions for drug discovery on a mission to exponentially increase the speed and quality of life-saving R&D to help bring new medicines to patients faster. We apply AI to understand how disease biology works throughout the drug discovery pipeline to solve the number one reason drug discovery projects fail—getting the biology wrong. Our platform, ASCEND, acts as a scalable AI assistant for preclinical organizations, increasing the productivity of the preclinical R&D pipeline across therapeutic areas. Backed by top-tier investors, including Generation Investment Management, iNovia Capital, TCV, F-Prime, Gradient Ventures (Google’s AI fund), and Golden Ventures, BenchSci has raised over $200 million. Our platform accelerates science at 16 top-20 pharmaceutical companies and over 4,500 leading research centers worldwide. We’re a Deloitte Technology Fast 50™ and Fast 500™ winner and a certified Great Place to Work®. For more information about BenchSci, visit www.benchsci.com.
About The Globe and Mail
The Globe and Mail is Canada’s foremost news media company, leading the national discussion and causing policy change through brave and independent journalism since 1844. With our award-winning coverage of business, politics and national affairs, The Globe and Mail newspaper reaches 6.2 million readers every week in our print or digital formats, and Report on Business magazine reaches 2.9 million readers in print and digital every issue. Our investment in innovative data science means that as the world continues to change, so does The Globe. The Globe and Mail is owned by Woodbridge, the investment arm of the Thomson family.
For more information, please contact Christina Peck at cpeck@benchsci.com.
